Platelet count threshold for hemorrhage in patients with immune thrombocytopenia treated with antiplatelet agents No … ← Venetoclax with Decitabine as Frontline Treatment for Younger Adults with Newly Diagnosed ELN Adverse-Risk AML Outcomes of Hematopoietic Stem Cell Gene Therapy for Wiskott-Aldrich Syndrome →